The key role of dual-energy X-ray absorptiometry (DXA) in the management of metabolic
bone diseases is well known. The role of DXA in the study of body composition and in the
clinical evaluation of disorders which directly or indirectly involve the whole metabolism as
they may induce changes in body mass and fat percentage is less known or less
understood. DXA has a range of clinical applications in this field, from assessing
associations between adipose or lean mass and the risk of disease to understanding and …